Novartis Q2 Core Profit Rises In Constant Currencies Excl. Roche Investment Impacts

Novartis (NVS) reported second quarter core net income of $3.4 billion, down 8%, or down 1% constant currencies, as growth in core operating income was more than offset by the loss of Roche core income. Excluding the impact of Roche core income, core net income increased 8% in constant currencies. Core EPS was $1.56, down 6%, or up 1% in cc. Excluding the impact of Roche core income, core EPS increased 10% in cc.

from RTT - Earnings https://ift.tt/UAmlQCz
via IFTTT